Cargando…
Study protocol for a randomised controlled trial evaluating the effects of the orexin receptor antagonist suvorexant on sleep architecture and delirium in the intensive care unit
INTRODUCTION: Insomnia frequently occurs in patients admitted to an intensive care unit (ICU). Sleep-promoting agents may reduce rapid eye movement sleep and have deliriogenic effects. Suvorexant (Belsomra) is an orexin receptor antagonist with Food and Drug Administration (FDA) approval for the tre...
Autores principales: | Azimaraghi, Omid, Hammer, Maximilian, Santer, Peter, Platzbecker, Katharina, Althoff, Friederike C, Patrocinio, Maria, Grabitz, Stephanie D, Wongtangman, Karuna, Rumyantsev, Sandra, Xu, Xinling, Schaefer, Maximilian S, Fuller, Patrick M, Subramaniam, Balachundhar, Eikermann, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371384/ https://www.ncbi.nlm.nih.gov/pubmed/32690536 http://dx.doi.org/10.1136/bmjopen-2020-038474 |
Ejemplares similares
-
Provider variability in the intraoperative use of neuromuscular blocking agents: a retrospective multicentre cohort study
por: Althoff, Friederike C, et al.
Publicado: (2021) -
Scheduled Prophylactic 6-Hourly IV AcetaminopheN to Prevent Postoperative Delirium in Older CaRdiac SurgicAl Patients (PANDORA): protocol for a multicentre randomised controlled trial
por: Khera, Tanvi, et al.
Publicado: (2021) -
Should asymptomatic patients testing positive for SARS-CoV-2 wait for elective surgical procedures?
por: Lieberman, Naama, et al.
Publicado: (2022) -
Protocol for an observational study of delirium in the post-anaesthesia care unit (PACU) as a potential predictor of subsequent postoperative delirium
por: Cui, Victoria, et al.
Publicado: (2017) -
Suvorexant: The first orexin receptor antagonist to treat insomnia
por: Dubey, Ashok K., et al.
Publicado: (2015)